Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Point and Frameshift Mutations01:30

Point and Frameshift Mutations

732
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
732
Amyloid Fibrils03:03

Amyloid Fibrils

11.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Mutations01:39

Mutations

94.2K
Overview
94.2K
Mutations01:35

Mutations

42.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.6K
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2022
Same author

DJ-1 regulates mitochondrial gene expression during ischemia and reperfusion.

Free radical biology & medicine·2022
Same author

Let's make science, not war!

Science advances·2022
Same author

Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.

Dystonia (Lausanne, Switzerland)·2022
Same author

Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18-Year Study.

Movement disorders : official journal of the Movement Disorder Society·2022
Same author

What if I could become the doctor I always wanted to be?

European journal of neurology·2022

Related Experiment Video

Updated: Jan 2, 2026

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
08:40

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

3.4K

The many faces of alpha-synuclein mutations.

Meike Kasten1, Christine Klein

  • 1Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 16, 2013
PubMed
Summary

Investigating alpha-synuclein (SNCA) mutations reveals distinct clinical patterns in Parkinson disease (PD). Specific SNCA mutations and multiplications influence age of onset, disease progression, and neurological symptoms.

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.2K

Related Experiment Videos

Last Updated: Jan 2, 2026

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
08:40

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

3.4K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.2K

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Alpha-synuclein (SNCA) gene mutations are a key focus in monogenic Parkinson disease (PD) research.
  • The discovery of a novel SNCA mutation, H50Q, prompted further investigation into genotype-phenotype correlations.

Purpose of the Study:

  • To systematically explore mutation-specific clinical expression in SNCA mutation carriers.
  • To compare the clinical phenotypes associated with different SNCA mutations and copy number variations.

Main Methods:

  • Systematic review of published literature on 145 SNCA mutation carriers.
  • Analysis of clinical data, including age at onset, disease course, and neurological features.

Main Results:

  • The A53T mutation is linked to an earlier onset (approx. 10 years) compared to other missense mutations like H50Q.
  • SNCA triplication leads to earlier onset and faster progression than duplication; higher-order multiplications are associated with myoclonus.
  • Non-motor symptoms, including depression, dementia, suicidal ideation, and hallucinations, manifest early and are severe.

Conclusions:

  • SNCA mutations, though rare, warrant continued genetic testing in Parkinson disease.
  • Differentiating SNCA mutations and variants offers insights into PD pathophysiology and aids clinical genetic counseling.